ABK Biomedical
ABK Biomedical Inc. is a Halifax, Nova Scotia medical device company founded in 2012 as a spin-out of Dalhousie University, developing and manufacturing imageable embolic microspheres for interventional oncology. Its lead product, Eye90 microspheres, is a yttrium-90 radioembolization device built on a proprietary imageable glass composition that is directly visible under fluoroscopy, X-ray and CT during and after the procedure, and it was granted FDA Breakthrough Device Designation for unresectable hepatocellular carcinoma and studied in the ROUTE90 pivotal trial. Its Easi-Vue embolic microspheres received FDA 510(k) clearance for embolization of hypervascular tumors and arteriovenous malformations. Devices are produced in the company's own cleanroom manufacturing facility in Halifax, with a second office in Ladera Ranch, California. ABK Biomedical is a regulated medical device manufacturer rather than a software vendor, and as of this profile it publishes no developer program, API documentation, SDK, or machine-readable API contract of any kind.
ABK Biomedical is profiled on the APIs.io network. Tagged areas include Medical Devices, Interventional Oncology, Radioembolization, Medical Imaging, and Oncology.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Company 2
The organization behind the API
Other 1
Properties that don't map to a standard resource type
Source (apis.yml)
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.